Kolexia
Rahal Arslane Oncologie médicale
Rahal Arslane
Oncologie médicale
Clcc Hopital Gustave Roussy
Chevilly-Larue, France
71 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibromatose agressive Carcinome pulmonaire non à petites cellules Sarcomes Carcinome pulmonaire à petites cellules Tumeurs du poumon Fibrome Tumeurs du sein Syndrome de Li-Fraumeni Tumeurs colorectales

Collaborateurs

Voir plus
Khalfallah Haroun Ali
Khalfallah Haroun Ali
Clcc Hopital Gustave Roussy, Chevilly-Larue, France
Guet Saada
Guet Saada
Centre Hospitalier de Provins , Provins, France
Sedrati Abdeslem
Sedrati Abdeslem
Cabinet libéral, Ris-Orangis, France
Bouaita Linda
Bouaita Linda
Centre De Radiotherapie De Ris Orangis, Ris-Orangis, France

Industries

Voir plus
B3TSI
123 collaboration(s)
Dernière en 2023
A+A
42 collaboration(s)
Dernière en 2023
M3 Global Research Ltd
33 collaboration(s)
Dernière en 2023
Axess Research
19 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.
Lung cancer (Amsterdam, Netherlands)   29 juillet 2017
Metronomic chemotherapy using oral etoposide in metastatic osteosarcoma.
2016 ASCO Annual Meeting I   20 mai 2016
Vinorelbine-based chemotherapy in metastatic epithelioid sarcoma.
2016 ASCO Annual Meeting I   20 mai 2016
Efficacy of oral vinorelbine in advanced/progressive desmoid tumours: An updated retrospective study in 50 patients.
2016 ASCO Annual Meeting I   20 mai 2016
Trabectedin as second line and beyond in advanced leiomyosarcoma.
2014 ASCO Annual Meeting I   20 mai 2014
Vinorelbine is an Active Drug in Desmoid Tumors / Aggressive Fibromatosis: Institut Gustave Roussy Experience
Abstract Book of the 37th ESMO Congress Vienna, Austria, 28 September - 2 October 2012   01 septembre 2012
P1.05 Upfront Genomic Testing for Patients With Non-Small Cell Lung Cancer Receiving First-Line Platinum-Based Regimen: Preliminary Result of the Msn Study
4th WIN Symposium: Efficacy of biomarkers and personalized cancer therapeutics 28–29 June 2012, Paris, France   01 juin 2012
High-dose ifosfamide (HDI) in metastatic synovial sarcoma: The Institut Gustave Roussy experience.
2012 ASCO Annual Meeting I   20 mai 2012
Hepatic arterial infusion (HAI) of oxaliplatin with either LV5FU2 or FOLFIRI in patients (pts) with refractory metastatic colorectal cancer (mCRC).
2011 ASCO Annual Meeting I   20 mai 2011
Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
Radiation oncology (London, England)   08 novembre 2010